-
- Posted Wednesday May 8, 2013
Ivy Foundation Renews Support for TGen Neurological Sciences Internship Program
Second year of training opportunities focused on brain tumors and neuroscience
PHOENIX, Ariz. - May 8, 2013 - The
Arizona-based Ben & Catherine Ivy Foundation will fund a second
year of the Ivy Neurological Science Internship Program at the
Translational Genomics Research Institute (TGen).
The internship program offers hands-on biomedical research
experience for high school, undergraduate and aspiring medical
school students pursuing careers in brain tumor research,
neuroscience and neurogenomics.
Through the program, world-class scientific investigators at TGen
guide interns in the translational process of moving laboratory
discoveries along the pipeline into new treatments for patients in
clinical trials.
"Based upon the success of the 2012 pilot year, we believe the Ivy
Neurological Science Internship Program at TGen will inspire a new
generation of leaders in this field," said Catherine Ivy, President
of The Ben & Catherine Ivy Foundation. "There is an urgent and
continuing need to encourage research into the intricate workings
of brain cancer."
TGen will select seven students for the program this year.
Starting in June, two high-school students will participate in a
10-week summer program. Four undergraduate students will spend the
fall semester at TGen, and one student planning to attend medical
school will participate for a full academic year, beginning in the
fall.
"Development of a local, knowledge-based workforce depends on
educating and training talented students in the latest aspects of
biomedical research and medicine," said TGen President Dr. Jeffrey
Trent. "The continued support from the Ivy program greatly enhances
our efforts to provide hands-on experience in the area of
translational research."
In addition to brain tumor and neurological sciences research
experience, Ivy interns will participate in a clinical training
module that will engage them with the ultimate focus of these
studies - the patient.
"TGen recognizes that we must invest in the development of the
next generation of researchers and physicians; we need to prepare
today's students for the complex and challenging work awaiting them
in the areas of brain tumor and neurological sciences research,"
said Brandy Wells, Manager of TGen's Education and Outreach.
For more information, please contact Brandy Wells at [email protected] or 602-343-8655.
# # #
About The Ben & Catherine Ivy
Foundation
The Ben & Catherine Ivy Foundation, based in Scottsdale,
Ariz., was formed in 2005, when Ben Ivy lost his battle with
glioblastoma multiforme (GBM). Since then, the Foundation has
contributed more than $50 million to research in gliomas within the
United States and Canada, with the goal of better diagnostics and
treatments that offer long-term survival and a high quality of life
for patients with brain tumors. The Ben & Catherine Ivy
Foundation is the largest privately funded foundation of its kind
in the United States. For more information, visit
www.ivyfoundation.org. Connect with The Ben & Catherine
Ivy Foundation on Facebook at www.facebook.com/IvyFoundation
and on Twitter @IvyFoundation.
*
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]